HyperMed, Inc. Garners $4,000,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=dbc79e96-3975-43c5-9fb5-878a10932222&Preview=1
Date
5/23/2008
Company Name
HyperMed, Inc.
Mailing Address
305 Second Avenue Waltham, MA 02451
Company Description
HyperMed, Inc., the leader in applying hyperspectral technology to medical applications. HyperMed’s flagship diagnostic device, OxyVu-1™, received U.S. Food and Drug Administration (FDA) clearance in November, 2006 for use in assessing patients for poor tissue circulation including those with diabetic foot ulcers, leg pain or other symptoms of poor blood flow.
Website
http://www.hypermed-inc.com
Transaction Type
Venture Equity
Transaction Amount
$4,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds will support ongoing marketing and sales of OxyVu, its lead product.
M&A Terms
Venture Investor
GBP Capital